? Congrats to the authors of this collaborative work between Johns Hopkins University School of Medicine, Xuchang University and Tsinghua University. ?
In this research, the authors observed that “nanozyme can block prion-like spreading, which provides a proof of concept for nanozyme therapy. It is also anticipated that the biomedical application of nanozyme against prion-like spreading could be optimized and considered to be developed as a therapeutic strategy against parkinson’s disease, alzheimer’s disease, and other prion-like proteinopathies.”